Functional MRI, drugs, and poststroke recovery

Clinical and Experimental Hypertension

Volumn 28, Issue 3-4, 2006, Pages 301-307

  Tombari, D ^a   Ricciardi, M C ^a   Bonaffini, N ^a   Pasquini, M ^a   Cecconi, M ^a   Di Piero, V ^a   Lenzi, G L ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Drug treatment; Functional magnetic resonance imaging; Poststroke recovery; Stroke

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; FLUOXETINE; HALOPERIDOL; IDAZOXAN; MAPROTILINE; METHOXAMINE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PRAZOSIN; SCOPOLAMINE; SEROTONIN AGONIST; DOPAMINE UPTAKE INHIBITOR;

BRAIN FUNCTION; BRAIN MAPPING; CONFERENCE PAPER; DEPRESSION; DISEASE EXACERBATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; HUMAN; LEARNING; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NEUROIMAGING; NONHUMAN; STROKE; VISUAL CORTEX; ANIMAL; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PROGNOSIS; REVIEW;

ANIMALS; CEREBROVASCULAR ACCIDENT; DOPAMINE UPTAKE INHIBITORS; HUMANS; MAGNETIC RESONANCE IMAGING; PHYSICAL THERAPY MODALITIES; PROGNOSIS; RECOVERY OF FUNCTION;

EID: 33746424918     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960600549348     Document Type: Conference Paper

References (44)

1. Feeney DM, Baron JC. Diaschisis. Stroke 1986; 17:817-830.
2. Dombovy ML, Bach-y-Rita P. Clinical observations on recovery from stroke. Adv Neurol 1988; 47:265-276.
3. Baron J, Bousser MG, Comar D, Castaigne P. Crossed cerebellar diaschisis in human supratentorial brain infarction. Trans Am Neurol Assn 1980; 105:459-461.
4. Perani D, Vallar G, Cappa S, Messa C, Fazio F. Aphasia and neglect after subcortical stroke. A clinical/cerebral perfusion correlation study. Brain 1987; 110:1211-1229.
5. Bowler JV, Wade JP, Jones BE, Nijran K, Jewkes RF, Cuming R, Steiner TJ. Contribution of diaschisis to the clinical deficit in human cerebral infarction. Stroke 1995; 26:1000-1006.
6. Infeld B, Davis SM, Lichtenstein M, Mitchell PJ, Hopper JL. Crossed cerebellar diaschisis and brain recovery after stroke. Stroke 1995; 26:90-95.
7. Seitz RJ, Azari NP, Knorr U, Binkofski F, Herzog H, Freund HJ. The role of diaschisis on stroke recovery. Stroke 1999; 9:1844-1850.
8. Marque P, Felez A, Puel M, Demonet JF, Guiraud-Chaumeil B, Roques CF, Chollet F. Impairment and recovery of left motor function in patients with right hemiplegia. J Neurol Neurosurg Psych 1997; 62:77-81.
9. Brodal A. Self-observations and neuro-anatomical considerations after a stroke. Brain 1973; 96:675-694.
10. Adams RW, Gandevia SC, Skuse NF. The distribution of muscle weakness in upper motoneuron lesions affecting the lower limb. Brain 1990; 113:1459-1476.
11. Tanji J, Okano K, Sato KC. Neuronal activity in cortical motor areas related to ipsilateral, contralateral, and bilateral digit movements of the monkey. J Neurophysiol 1988; 60:325-343.
12. Chollet F, DiPiero V, Wise RJS, Brooks DJ, Dolan RJ, Frackowiak RSJ. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991; 29:63-71.
13. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK, et al. A fMRI study of subjects recovered from hemiparetic stroke. Stroke 1997; 28:2518-2527.
14. Netz Y, Argov E. Assessment of functional fitness among independent older adults: a preliminary report. Percept Mot Skills 1997; 84:1059-1074.
15. Weiller C, Ramsay SC, Wise RJS, Friston KJ, Frackowiak RSJ. Individual patterns of functional reorganisation in the human cerebral cortex after capsular infarction. Ann Neurol 1993; 33:181-189.
16. Dolphin AC, Errington ML, Bliss TV. Long-term potentiation of the perforant path in vivo is associated with increased glutamate release. Nature 1982; 297:496-498.
17. Corbett D. Long-term potentitation of lateral hypothalamic self-stimulation following parabrachial lesion in the rat. Brain Res Bull 1980; 5:637-642.
18. Aroniadou VA, Teyler TJ. The role of NMDA receptors in long-term potentiation (LTP) and depression (LTD) in rat visual cortex. Brain Res 1991; 18:136-143.
19. Keller A, Iriki A, Asanuma H. Identification of neurons producing long term potentiation in the cat motor cortex: intracellular recording and labelling. J Comp Neurol 1990; 300:47-60.
20. Dahl D, Sarvey JM. Norepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus. Proc Natl Acad Sci USA 1989; 86:4776-4780.
21. Olpe HR, Karlsson G. The effects of baclofen and two GABAB-receptor antagonists on long-term potentiation. Naunyn Schmiedebergs Arch Pharmacol 1990; 342:194-197.
22. Goldstein LB. Pharmacologic interventions for impoving functional tasks and altering brain behaviour. In Imaging in Neurorehabilitation. New York: Demos Vermande, 1996; 155-169.
23. Jones TA, Chu CJ, Grande LA, Gregory AD. Motor skills training enhances lesion-induced structural plasticity in the motor cortex of adult rats. J Neurosci 1999; 19:10153-10163.
24. Greenough WT, Larson JR, Withers GS. Effects of unilateral and bilateral training in a reaching task on dendritic branching of neurons in the rat motor-sensory forelimb cortex. Behav Neural Biol 1985; 44:301-314.
25. Dietrich WD, Alonso O, Busto R, Watson BD, Loor Y, Ginsberg MD. Influence of amphetamine treatment on somatosensory function of the normal and infarcted rat brain. Stroke 1990; 21:147-150.
26. Hopkins WF, Johnston D. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science 1984; 226:350-352.
27. Goldstein LB. Common drugs may influence motor recovery after stroke. The Sygen in Acute Stroke Study Investigators. Neurology 1995; 45:865-871.
28. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217:855-857.
29. Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23:94-97.
30. Dromerick AW, Reding MJ. Functional outcome for patients with hemiparesis, hemihypesthesia, and hemianopsia Does lesion location matter? Stroke 1995; 26:2023-2026.
31. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995; 26:2254-2259.
32. Gustafson I, Westerberg E, Wieloch T. Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action. J Cereb Blood Flow Metab 1990; 10:885-894.
33. Araki T, Kogure K, Izumiyama K. Prevention of ischemic neuronal damage by alpha 1-adrenoceptor agonist (methoxamine). Acta Neurol Scand 1989; 80:451-454.
34. Feeney DM, Westerberg VS. Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 1990; 44:233-252.
35. Sabe L, Salvarezza F, Garcia Cuerva A, Leiguarda R, Starkstein S. A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995; 45:2272-2274.
36. Bragoni M, Altieri M, Di Piero V, Padovani A, Mostardini C, Lenzi GL. Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurol Sci 2000; 21:19-22.
37. Lazar RM, Fitzsimmons BF, Marshall RS, Berman MF, Bustillo MA, Young WL, et al. Reemergence of stroke deficits with midazolam challenge. Stroke 2002; 30:283-285.
38. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke 1987; 18:837-843.
39. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27:1211-1214.
40. Glanzman DL. Postsynaptic regulation of the development and long-term plasticity of Aplysia sensorimotor synapses in cell culture. J Neurobiol 1994; 25:666-693.
41. Hrdina PD, Vu TB. Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 1993; 14:324-331.
42. Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro P, et al. Post-stroke depression, antidepressant treatment and rehabilitation results A case-control study. Cerebrovasc Dis 2001; 12:264-271.
43. Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001; 50:718-729.
44. Lyeth BG, Ray M, Hamm RJ, Schnabel J, Saady JJ, Poklis A, et al. Postinjury scopolamine administration in experimental traumatic brain injury. Brain Res 1992; 569:281-286.